RU2012122535A - INACTIVATED BIRD VACCINE - Google Patents
INACTIVATED BIRD VACCINE Download PDFInfo
- Publication number
- RU2012122535A RU2012122535A RU2012122535/15A RU2012122535A RU2012122535A RU 2012122535 A RU2012122535 A RU 2012122535A RU 2012122535/15 A RU2012122535/15 A RU 2012122535/15A RU 2012122535 A RU2012122535 A RU 2012122535A RU 2012122535 A RU2012122535 A RU 2012122535A
- Authority
- RU
- Russia
- Prior art keywords
- virus
- turkeys
- adjuvant
- water
- newcastle disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
1. Применение иммуногенного количества инактивированного вируса ньюкаслской болезни и адъюванта типа «вода в масле» для получения бустерной вакцины, предназначенной для вакцинации кур или индеек, которые за 2-12 недель до вакцинирования бустерной вакциной были вакцинированы первичной вакциной, содержавшей иммуногенное количество инактивированного вируса ньюкаслской болезни и адъювант типа «вода в масле».2. Фармацевтическая композиция, содержащая иммуногенное количество инактивированного вируса ньюкаслской болезни и адъювант типа «вода в масле», для применения в лечении ньюкаслской болезни у кур или индеек, где указанное лечение включает стадии проведения первичной вакцинации указанных кур или индеек вакциной, содержащей иммуногенное количество инактивированного вируса ньюкаслской болезни и адъювант типа «вода в масле», и проведение бустерной вакцинации спустя 2-12 недель после указанной первичной вакцинации указанных кур или индеек вакциной, содержащей иммуногенное количество инактивированного вируса ньюкаслской болезни и адъювант типа «вода в масле».3. Фармацевтическая композиция по п.2, отличающаяся тем, что указанная композиция содержит один или более дополнительных антигенов, произведенных из вируса или микроорганизма, патогенного для птицы, или генетическую информацию, кодирующую указанный антиген.4. Фармацевтическая композиция по п.3, отличающаяся тем, что указанный вирус или микроорганизм выбирают из группы, состоящей из вируса инфекционного бронхита, вируса инфекционного бурсита (болезни Гумборо), возбудителя куриной анемии, реовируса птиц, Mycoplasma gallisepticum, вируса ринотрахеита индеек, Haemop1. The use of an immunogenic amount of inactivated Newcastle disease virus and a water-in-oil adjuvant to produce a booster vaccine intended for vaccinating chickens or turkeys that were vaccinated 2-12 weeks before vaccination with a booster vaccine containing an immunogenic amount of inactivated Newcastle virus diseases and adjuvant of the “water in oil” type. 2. A pharmaceutical composition comprising an immunogenic amount of an inactivated Newcastle disease virus and a water-in-oil adjuvant for use in treating Newcastle disease in chickens or turkeys, wherein said treatment comprises the steps of initially vaccinating said chicken or turkeys with a vaccine containing an immunogenic amount of inactivated Newcastle virus diseases and adjuvant of the "water in oil" type, and booster vaccination 2-12 weeks after the specified primary vaccination of these chickens or turkeys in ktsinoy comprising an immunogenic amount of inactivated Newcastle disease virus and an adjuvant such as "water in oil" .3. The pharmaceutical composition according to claim 2, characterized in that said composition contains one or more additional antigens derived from a virus or microorganism pathogenic for poultry, or genetic information encoding said antigen. The pharmaceutical composition according to claim 3, characterized in that said virus or microorganism is selected from the group consisting of infectious bronchitis virus, infectious bursitis virus (Gumboro disease), causative agent of chicken anemia, bird reovirus, Mycoplasma gallisepticum, turkey rhinotracheitis virus, Haemop
Claims (5)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26551909P | 2009-12-01 | 2009-12-01 | |
US61/265,519 | 2009-12-01 | ||
EP09177634.4 | 2009-12-01 | ||
EP09177634 | 2009-12-01 | ||
PCT/EP2010/068464 WO2011067224A1 (en) | 2009-12-01 | 2010-11-30 | Inactivated poultry vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2012122535A true RU2012122535A (en) | 2014-01-20 |
RU2545530C2 RU2545530C2 (en) | 2015-04-10 |
Family
ID=41724692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012122535/15A RU2545530C2 (en) | 2009-12-01 | 2010-11-30 | Inactivated vaccine for poultry |
Country Status (6)
Country | Link |
---|---|
US (1) | US20120231033A1 (en) |
EP (1) | EP2506872A1 (en) |
CN (1) | CN102639148A (en) |
BR (1) | BR112012012921A2 (en) |
RU (1) | RU2545530C2 (en) |
WO (1) | WO2011067224A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103495160B (en) * | 2013-10-08 | 2015-11-18 | 南京天邦生物科技有限公司 | The preparation method of chicken Mycoplasma synoviae inactivated vaccine |
CN103585628B (en) * | 2013-11-21 | 2016-08-17 | 青岛润达生物科技有限公司 | A kind of immunoglobulin preparation preventing Newcastle disease and preparation method thereof |
CN104885994A (en) * | 2015-05-04 | 2015-09-09 | 霍邱县科瑞达禽业有限公司 | Drinking water immunization method for chicken flock |
CN107446858B (en) * | 2017-09-02 | 2020-11-03 | 河南省农业科学院畜牧兽医研究所 | Pigeon mycoplasma and application thereof |
CN109486741B (en) * | 2018-12-20 | 2021-10-29 | 天津瑞普生物技术股份有限公司 | Method for inactivating avibacterium paragallinarum |
WO2023168057A2 (en) * | 2022-03-03 | 2023-09-07 | Luberski, Inc. Dba Hidden Villa Ranch | Salmonella free egg production methods and systems |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2181862C (en) * | 1995-08-01 | 2009-12-22 | Carla Christina Schrier | Mild newcastle disease virus vaccine |
ZA978434B (en) * | 1996-09-27 | 1998-03-26 | Akzo Nobel Nv | Inactivated vaccines. |
US7378101B2 (en) * | 2001-12-21 | 2008-05-27 | Pfizer, Inc. | Vaccine for periodontal disease |
-
2010
- 2010-11-30 CN CN2010800545906A patent/CN102639148A/en active Pending
- 2010-11-30 WO PCT/EP2010/068464 patent/WO2011067224A1/en active Application Filing
- 2010-11-30 EP EP10787375A patent/EP2506872A1/en active Pending
- 2010-11-30 US US13/510,640 patent/US20120231033A1/en not_active Abandoned
- 2010-11-30 RU RU2012122535/15A patent/RU2545530C2/en not_active IP Right Cessation
- 2010-11-30 BR BR112012012921A patent/BR112012012921A2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20120231033A1 (en) | 2012-09-13 |
CN102639148A (en) | 2012-08-15 |
BR112012012921A2 (en) | 2016-10-25 |
WO2011067224A1 (en) | 2011-06-09 |
RU2545530C2 (en) | 2015-04-10 |
EP2506872A1 (en) | 2012-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2012122535A (en) | INACTIVATED BIRD VACCINE | |
Glisson | Bacterial respiratory disease of poultry | |
AR099470A1 (en) | LIQUID CORRAL BIRD VIRUS VACCINES | |
RU2008138702A (en) | WAYS AND COMPOSITIONS FOR VACCINATION OF Poultry | |
RU2013156673A (en) | IMMUNITY MULATING OLIGODESOXINUCLEOTIDES | |
RU2013156635A (en) | IMMUNITY MULATING OLIGODESOXINUCLEOTIDES | |
RU2007128047A (en) | PASTEURELLA MULTOCIDA VACCINE | |
RU2019102170A (en) | DUCK ENTERITIS VIRUS AND ITS APPLICATION | |
US20080026449A1 (en) | Infectious Bronchitis Virus Vaccine | |
van Empel | Ornithobacterium rhinotracheale | |
CA2429120A1 (en) | Salmonella vaccine | |
RU2018103145A (en) | Duck Enteritis Virus and Its Use | |
Gong et al. | Safety and efficacy studies on trivalent inactivated vaccines against infectious coryza | |
EP1259257B1 (en) | In ovo protection against infectious bronchitis | |
Al-Ebshahy et al. | Protection conferred by a vaccine derived from an inactivated Egyptian variant of infectious bronchitis virus: a challenge experiment | |
Ahmad et al. | Evaluation of two vaccination schemes using live vaccines against Newcastle disease in chickens | |
Ezeibe et al. | In vitro and in vivo effects of aluminium magnesium silicate on infectious bursal disease virus in chicken. | |
RU2021117820A (en) | VACCINE AGAINST INFECTIOUS BRONCHITIS | |
Yousif et al. | Oral administration of hyperimmune IgY: an immunoecological approach to curbing acute infectious bursal disease virus infection | |
US7208164B2 (en) | Ovo immunization against infectious bronchitis | |
Salman et al. | Role of a locally prepared bivalent inactivated Infectious Bronchitis Virus (IBV) vaccine within vaccination program to control infectious bronchitis disease in layer chickens. | |
Breytenbach | Guidelines for effective vaccination of broilers | |
Parvin et al. | Humoral immune response to fowl cholera vaccine in different breeds of commercial birds. | |
Ilyas et al. | Evaluation of Egg Drop Syndrome Virus Vaccines by Measuring Antibody Levels in Egg Yolk in Layers | |
Hassanzadeh et al. | Evaluation of the immunogenisity of immune complex infectious bursal disease vaccine delivered in ovo to embryonated eggs or subcutaneously to day-old chickens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20181201 |